Improving survivorship care for rural adult cancer survivors
KanSurvive 2.0
This project compares education, tele-mentoring, and adding virtual medical-assistant scribes to help primary care teams give more guideline-based follow-up care to rural adult cancer survivors.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project ID | NIH-11134671 on NIH RePORTER |
What this research studies
If you are a rural adult cancer survivor, this project works with your primary care clinic to try to improve long-term follow-up and management of treatment effects. Clinics are randomly assigned to one of three approaches: extra provider education and tele-mentoring, virtual scribes acting as trained medical assistants, or usual care. The research team will track whether these approaches lead to more guideline-based screening, management of chronic problems, and better coordination across health systems. They will also use practical implementation tools to learn what helps or gets in the way of putting these changes into practice.
Who could benefit from this research
Good fit: Adults (21 years and older) who are cancer survivors receiving care from participating primary care clinics, including breast cancer survivors, are ideal candidates.
Not a fit: People under 21, those currently in active cancer treatment, or patients whose primary care is not at a participating clinic are unlikely to benefit directly from this project.
Why it matters
Potential benefit: If successful, this could lead to more consistent, evidence-based follow-up care and better management of long-term effects for rural cancer survivors.
How similar studies have performed: Prior work shows provider education and tele-mentoring can improve guideline uptake, while the use of virtual scribes in survivorship care is a newer approach with limited prior data.
Where this research is happening
Kansas City, United States
- University of Kansas Medical Center — Kansas City, United States (Active)
Researchers
- Principal investigator: Greiner, K Allen — University of Kansas Medical Center
- Study coordinator: Greiner, K Allen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.